We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Amgen Acquires Medigene Cancer Spin-Off
Baxalta, Momenta Provide Update on Proposed Humira Biosimilar, Adynovate Shines in Phase 3
EMA Eyes New Drug Access, Collaboration by 2020
Boehringer’s Lung Cancer Compound Snags FDA’s Breakthrough Therapy Designation
Shkreli Out as KaloBios CEO
FDA Focuses on Supplements by Elevating Division to an Office
ICH Releases Genomic Sample Collection Draft Guidance